“No Compromise on Safety”: Indian vaccine manufacturers reaffirm safety of Covid-19 vaccines

New Delhi: In a statement, Dr. G.V.J.A. Harshavardhan, Director General, Indian Vaccine Manufacturers’ Association (IVMA), affirmed that India’s COVID-19 vaccines were developed and produced adhering to the highest standards of safety and quality.

“Patient safety and product quality have always been top priorities throughout the development and manufacturing of COVID-19 vaccines in India,” he said. “All vaccines received Emergency Use Authorization in line with WHO guidelines, based on rigorous preclinical and clinical evaluations demonstrating strong safety, efficacy, and immune response.”

Dr. Harshavardhan emphasized that every batch of COVID-19 vaccines underwent stringent safety testing by manufacturers and received Batch Release Certification from the Central Drugs Laboratory (CDL), Kasauli, under the Ministry of Health and Family Welfare.

Highlighting India’s strengths in innovation and large-scale, high-quality manufacturing, he credited Indian-made vaccines for playing a critical role in controlling the pandemic, saving lives, protecting livelihoods, and driving India’s economic recovery.

“This positive impact extended globally through the Government of India’s Vaccine Maitri initiative, which enabled vaccine access to many countries,” he added. “We strongly reassure the public of the proven safety and effectiveness of COVID-19 vaccines.”

The post “No Compromise on Safety”: Indian vaccine manufacturers reaffirm safety of Covid-19 vaccines appeared first on BioVoiceNews.

News